Is a listed NDC number the same as FDA approval? FDA’s own words
Is a listed NDC the same as FDA approval?
No. FDA’s NDC Directory page says: “Assignment of an NDC number does not in any way denote FDA approval of the product. Any representation that creates an impression of FDA approval because a product has an NDC number is misleading and violates federal law.” Of the 467 GLP-1 listings in FDA’s NDC files read Nov 15, 2026, 109 carry an NDA, ANDA, BLA or NDA authorized generic category with an application number, and 358 carry other categories, such as compounded products and bulk ingredients.
FDA’s own words on the NDC Directory page (content current as of Mar 4, 2026):
Inclusion in the NDC Directory does not indicate that FDA has verified the information provided or that the products are FDA-approved. The content of each NDC Directory entry is the responsibility of the labeler submitting the SPL file. Assignment of an NDC number does not in any way denote FDA approval of the product. Any representation that creates an impression of FDA approval because a product has an NDC number is misleading and violates federal law. Inclusion in the NDC Directory or assignment of an NDC number does not mean a product is a drug as defined by federal law.
FDA’s NDC product file definitions add: “Assignment of an NDC number does not in any way denote FDA approval of the product. Any representation that creates an impression of official approval because of possession of an NDC number is misleading and constitutes misbranding (21 CFR 207.37 (a)(2)).”
GLP-1 listings by marketing category
The marketing category is the labeler’s own entry, shown as FDA’s file gives it. An application number is the NDA, ANDA or BLA the labeler reports; FDA’s definitions say that for unapproved drugs “this field will be null.”
| Carries an application number | ||
|---|---|---|
| BULK INGREDIENT | 147 | No |
| NDA | 91 | Yes, all |
| OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS) | 75 | No |
| DRUG FOR FURTHER PROCESSING | 69 | No |
| BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING | 67 | No |
| ANDA | 15 | Yes, all |
| NDA AUTHORIZED GENERIC | 2 | Yes, all |
| BLA | 1 | Yes, all |
How to read an NDC listing
An NDC is FDA’s identifier for a listed product. The marketing category field says what the labeler reports the product to be: “NDA” or “ANDA” for products marketed under an FDA application, “OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)” for an outsourcing facility’s compounded product, “BULK INGREDIENT” for an active ingredient. Search a product NDC on the GLP-1 NDC listings page to see its category.
Common questions
Does an NDC mean a product is a drug as defined by law?
FDA says: “Inclusion in the NDC Directory or assignment of an NDC number does not mean a product is a drug as defined by federal law.”
Who is responsible for what an NDC listing says?
FDA says: “The content of each NDC Directory entry is the responsibility of the labeler submitting the SPL file.”
Are compounded semaglutide products in the NDC Directory?
Outsourcing facilities that elect to assign NDCs report them; FDA’s compounded drugs file read Nov 15, 2026 lists 38 semaglutide products under the category “OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)”.
Sources
- FDA National Drug Code Directory (download files)
- FDA: NDC product file definitions
- openFDA drug NDC endpoint (count cross-check)
Records last pulled Nov 15, 2026. Every entry links to the original public record.